Eli Lilly has introduced a completely new application that allows self-pay out clients to purchase the weight-loss drug Zepbound for as tiny as $399 per 30 days—below 50 % the record price of other incretin medicines employed for sufferers with obesity.It’s even more practical than its rival, semaglutide, promoted as copyright for type 2 diabet… Read More